| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0009 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |